These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11362548)

  • 1. The Inter-Company Collaboration for AIDS Drug Development: boon or bust?
    Levin J
    BETA; 1995 Jun; ():65-6. PubMed ID: 11362548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future of ICC debated. Inter-Company Collaboration for AIDS Drug Development.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):9. PubMed ID: 11362692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-Company Collaboration Combination Trials. Clinical Trial Subcommittee of the Inter-Company Collaboration for AIDS Drug Development.
    Soo W; Nauss-Karol C; Elkins M; Rooney J; Barry DW
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 2():S92-6. PubMed ID: 7552520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug companies seek trial participants.
    AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New combo trial/same old style.
    Gilden D
    GMHC Treat Issues; 1995 Apr; 9(4):9. PubMed ID: 11362369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-drug combos.
    Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug consortium seeks trial participants.
    Grodeck B
    Posit Aware; 1995; ():9. PubMed ID: 11362385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ICC Trials -- first study enrolling.
    James JS
    AIDS Treat News; 1995 Mar; (no 219):8. PubMed ID: 11362334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded access to the protease inhibitor drugs.
    Baker R
    BETA; 1995 Jun; ():67. PubMed ID: 11362549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New trial proposed for when drugs fail.
    James JS
    AIDS Treat News; 1995 May; (no 223):1-4. PubMed ID: 11362467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors and prevention of cross resistance.
    Levin J
    AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ongoing protease inhibitor trials.
    GMHC Treat Issues; 1995 Jun; 9(6):2. PubMed ID: 11362688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease inhibitor expanded access.
    Smart T
    GMHC Treat Issues; 1995 Jun; 9(6):3. PubMed ID: 11362689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roche investigators say Invirase does not cause cross-resistance to other protease inhibitors.
    Baker R
    BETA; 1995 Sep; ():5. PubMed ID: 11362895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitor update: treatment combination strategies.
    Mascolini M
    AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efavirenz DuPont Pharmaceuticals Co.
    Dong BJ
    IDrugs; 1998 Oct; 1(6):700-11. PubMed ID: 18465625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease inhibitor: Roche lottery deadline July 21.
    AIDS Treat News; 1995 Jul; (no 226):4-5. PubMed ID: 11362614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.